SHIFT Newsroom · GLOBAL
Trial record: blood levels after two CagriSema formulations
Registry status checked on 3 October 2026: completed.
ClinicalTrials.gov lists NCT06716307, concerning blood levels after two CagriSema formulations, as completed. The record was first posted on 2024-12-04 and last updated on 2026-08-31; SHIFT checked it on 3 October 2026. The recorded study-completion date is 2025-03-28.
This phase 1 crossover study compares drug concentrations in blood. Pharmacokinetic comparisons are not proof of clinical weight-loss effectiveness.
No results tables were posted in this registry record when checked. That does not establish that no results have been published elsewhere. A registry entry is not a UK marketing authorisation or confirmation of NHS access.
SHIFT’s take
Keep the trial status, published results and UK treatment access separate. Do not change treatment on the basis of a registration.
For the wider picture, read our CagriSema UK guide: availability, trial evidence and alternatives.